# Task V7: Clinical and NHP Sample Testing for SARS-CoV-2 Biological Product Candidates

> **NIH NIH N01** · BATTELLE CENTERS/PUB HLTH RES & EVALUATN · 2021 · $172,276

## Abstract

The Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases contract provides a variety of product development services from early feasibility studies through activities required for the submission of Biologic License Application (BLA) and/or Investigational New Drug (IND) applications. These services will facilitate the development and introduction of new biologics (regulated by CBER) against potential agents of bioterrorism and emerging and re-emerging infectious diseases.

## Key facts

- **NIH application ID:** 10329730
- **Project number:** 272201800013I-P00002-759302000004-3
- **Recipient organization:** BATTELLE CENTERS/PUB HLTH RES & EVALUATN
- **Principal Investigator:** THOMAS RUDGE
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $172,276
- **Award type:** —
- **Project period:** 2020-08-27 → 2022-08-26

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10329730

## Citation

> US National Institutes of Health, RePORTER application 10329730, Task V7: Clinical and NHP Sample Testing for SARS-CoV-2 Biological Product Candidates (272201800013I-P00002-759302000004-3). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/10329730. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*